Will Weight Loss Pills Replace Weight Loss Injections?

As a pharmacist, I've lost count of how many times I've been asked this since the MHRA licensed the UK's first weight loss tablet, the oral Wegovy pill. It's a fair question, given how quickly this area of medicine is moving. I want to talk you through what the evidence tells us, why I don't think injections are about to disappear, and the questions I'd encourage any patient to think about before deciding which option might suit them best.

Are Weight Loss Pills as Effective as Injections?

When I look at the trial data, the difference appears relatively small for most people, although it isn't necessarily zero. Clinical trial data submitted to regulators in the UK and internationally suggests that oral semaglutide, the active ingredient in the Wegovy pill, produces weight loss broadly comparable to injectable semaglutide over similar treatment periods.

I'd also flag that some injectable medicines, particularly those that act on more than one appetite-related hormone, have shown somewhat greater average weight loss in their own trials than currently available tablets. I'm always a bit cautious about comparing results across separate studies like this, though, since trial populations and conditions vary.

If a patient asks me to sum it up in one sentence, I'd say neither format has been shown to be dramatically better than the other for most people. In practice, the choice often comes down to what fits someone's lifestyle and preferences.

Since both medicines contain semaglutide, they also have broadly similar side-effect profiles, with nausea, vomiting and diarrhoea among the most common. Individual experiences vary, and a registered prescriber can explain the potential benefits and risks of each option. Our guide on Wegovy tablets versus Wegovy injections looks at this comparison in more detail.

Why Are Pills Becoming More Popular?

From what I see day to day, tablets are gaining ground mainly because they suit people who wouldn't otherwise consider treatment. Two reasons come up consistently when I talk to patients.

• Quite a few people are simply put off by needles, even when they might benefit from treatment.
• Injectable pens have faced supply shortages in recent years, so tablets give manufacturers another way to meet demand.

For some people, taking a tablet every morning simply feels easier to remember. Others like the idea of a once-weekly injection because there's less to think about from one day to the next. Choosing the option you're most likely to take consistently can make a real difference to long-term treatment.

I'd stress that none of this means a tablet works better. In my experience, the appeal is mostly about convenience and access, not superior results.

What Has Been Approved in the UK So Far?

I was genuinely pleased to see the MHRA approve oral semaglutide, sold as the Wegovy pill, in June 2026, making it the UK's first weight loss tablet in this drug class. It's licensed for adults with a BMI of 30 or above, or a BMI of 27 to 30 with a weight-related health condition, alongside a reduced-calorie diet and increased physical activity.

The tablet is currently only available privately, since NHS use depends on a future appraisal by NICE. Injectable options, including Wegovy and Mounjaro, remain widely used and, in some cases, more established within NHS pathways.

Will Pills Fully Replace Injections, or Will Both Continue to Be Used?

Based on what I'm seeing in the pipeline, full replacement looks unlikely in the near term. Several manufacturers are still developing new injectable medicines alongside tablets, which tells me the industry itself doesn't expect one format to disappear. Other oral GLP-1 medicines are also progressing through trials, as covered in our piece on orforglipron in clinical research.

Market analysts have made similar predictions. Some forecasts suggest oral medicines could capture around a quarter of the global weight loss drug market by 2030, which points to significant growth for tablets, but injections retaining the larger overall share.

In practice, I think this probably means more choice rather than a straightforward changeover. Some patients will prefer tablets, others will continue with injections, and some may move between the two over time under medical supervision.

What Would I Want You to Consider Before Choosing Between a Pill and an Injection?

In my consultations, the right choice depends on your own health, preferences, and medical history, not on which format happens to be newer. A few practical points are always worth thinking through beforehand.

• Both are prescription-only medicines, so neither is available without a proper assessment by a registered prescriber.
• Existing health conditions and current medication can affect which option, if any, is suitable.
• Oral semaglutide has specific dosing instructions. It must be taken on an empty stomach with a small amount of water before eating, drinking or taking other medicines, whereas injections are given once weekly.
• Lifestyle changes, including diet and physical activity, remain part of any sensible treatment plan regardless of format.

Our guide on how the Wegovy pill compares with Mounjaro covers some of these differences in more detail, as does our piece on whether tablets or Mounjaro injections are the safer choice.

How Pharmacy Planet Helps You Choose Between Tablets and Injections

Working out whether a tablet or an injection might suit you is exactly the kind of question I'd want you to bring to a proper consultation, rather than something to try to resolve alone from an article.

At Pharmacy Planet, every treatment request goes through a confidential online consultation with a UK-registered prescriber. Here's what that process involves:

• You complete a short online health questionnaire covering your medical history, current medication, and weight-related health conditions.
• A registered prescriber reviews your answers, checks eligibility and flags anything that needs a closer look.
• If a treatment is appropriate, they'll talk you through the realistic options, including tablets and injections, so you can make an informed decision together.
• Nothing is dispensed until that assessment is complete, and you're free to ask questions at any stage.

You can start your consultation here or find out more about eligibility first on our oral Wegovy pill page.

This article reflects my professional perspective as a pharmacist and is for general information only. It does not constitute personal medical advice. Prescription-only medicines are available only following a consultation with a registered prescriber, who will confirm whether treatment is appropriate for you.

Frequently Asked Questions

Is one type of weight loss medicine more effective than the other?

Not dramatically. Trial evidence suggests broadly similar weight loss between currently available tablets and their equivalent injections, though results vary between individuals and between specific medicines. Some injectable medicines that act on more than one hormone pathway have shown somewhat greater average weight loss in their own trials, but I'd caution against reading too much into comparisons across separate studies, so this isn't a guarantee of what any one person will experience.

Will the Wegovy pill eventually be available on the NHS?

Not yet, from what I can tell. It's currently available privately, following a consultation with a registered prescriber, and NHS access depends on a future appraisal by NICE. NICE appraisals weigh up clinical effectiveness against cost before making a recommendation, and that process typically takes time, so I wouldn't expect NHS availability in the short term.

Can I switch from an injection to a tablet, or the other way round?

This is possible in some cases, but only under the guidance of a registered prescriber, who can assess whether switching is appropriate for your circumstances. Dosing schedules differ between formats, so I'd never recommend managing a switch independently.

Are there weight loss injections that do not have a tablet equivalent yet?

Yes. Several injectable medicines, including those that act on more than one hormone pathway, aren't currently available in tablet form in the UK, though manufacturers are developing oral versions. Retatrutide is one example, and our guide on what retatrutide is and how it works explains this in more detail.

Are more oral weight loss medicines expected in the UK soon?

Yes, several are progressing through development or regulatory review, as far as I'm aware. Eli Lilly's orforglipron, for example, has been approved in the United States but hasn't yet received MHRA approval in the UK, and other companies are working on their own oral candidates.

Do weight loss pills work faster than injections?

Not necessarily. Both tablets and injections are introduced gradually to help reduce side effects, so weight loss tends to build over time rather than happening immediately. Results vary between individuals, and following the prescribed dosing schedule and lifestyle advice is more important than the format of the medicine.

Could injections eventually stop being used altogether?

I think that looks unlikely in the foreseeable future. Some of the most effective injectable medicines, particularly those acting on multiple hormone pathways, don't yet have a tablet equivalent, and NHS treatment pathways are still largely built around injections. Tablets are expected to take a growing share of the market, but in my view both formats are likely to be prescribed alongside each other for some years yet.

How do I decide which option is right for me?

This depends on your medical history, any existing health conditions, current medication and your own preference around needles versus tablets. Some patients are also guided by practical factors, such as how a medicine needs to be stored or taken. Rather than trying to weigh this up alone, I'd always recommend talking it through with a registered prescriber during a consultation so they can explain the reasoning behind whatever they suggest.